Healthcare >> CEO Interviews >> October 17, 2003
C. BOYD CLARKE has been President and Chief Executive Officer of Neose
Technologies, Inc., since March 2002 and Chairman of the Board since May
2003. From December 1999 through March 2002, Mr. Clarke was President
and Chief Executive Officer of Aviron, a biotechnology company, and was
also Chairman from January 2001 through March 2002. From 1998 through
1999, Mr. Clarke was Chief Executive Officer and President of U.S.
Bioscience, Inc., also a biotechnology company. Mr. Clarke served as
President and Chief Operating Officer of U.S. Bioscience, Inc., from
1996 to 1998. From 1977 to 1996, Mr. Clarke held a number of positions
at Merck & Co., Inc., including being the first President of Pasteur-
Merieux MSD, and most recently as Vice President of Merck Vaccines. Mr.
Clarke has a BS in Biochemistry and an MA in History from the University
of Calgary. Profile
Mr. Clarke: Neose is developing next generation proteins by using our
proprietary technologies to improve currently marketed proteins.
